DE4118912C1 - - Google Patents

Info

Publication number
DE4118912C1
DE4118912C1 DE4118912A DE4118912A DE4118912C1 DE 4118912 C1 DE4118912 C1 DE 4118912C1 DE 4118912 A DE4118912 A DE 4118912A DE 4118912 A DE4118912 A DE 4118912A DE 4118912 C1 DE4118912 C1 DE 4118912C1
Authority
DE
Germany
Prior art keywords
chromatography
antibody
sterilization
hydrophobic phase
igg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE4118912A
Other languages
German (de)
English (en)
Inventor
Norbert Dipl.-Chem. Dr. 6242 Kronberg De Kothe
Dieter Dipl.-Chem. Dr. 6072 Dreieich De Rudnick
Detlef Dipl.-Biol. Dr. 6100 Darmstadt De Rohm
Ulf Dr. 6074 Roedermark De Bethke
Michael Dipl.-Chem. Dr. 6100 Darmstadt De Kloft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma 6072 Dreieich De GmbH
Original Assignee
Biotest Pharma 6072 Dreieich De GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE4118912A priority Critical patent/DE4118912C1/de
Application filed by Biotest Pharma 6072 Dreieich De GmbH filed Critical Biotest Pharma 6072 Dreieich De GmbH
Priority to DE59208982T priority patent/DE59208982D1/de
Priority to EP92108912A priority patent/EP0530447B1/de
Priority to DK92108912.4T priority patent/DK0530447T3/da
Priority to ES92108912T priority patent/ES2108059T3/es
Priority to AT92108912T priority patent/ATE159532T1/de
Priority to JP4145807A priority patent/JP2644946B2/ja
Application granted granted Critical
Publication of DE4118912C1 publication Critical patent/DE4118912C1/de
Priority to GR970403248T priority patent/GR3025603T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE4118912A 1991-06-08 1991-06-08 Expired - Fee Related DE4118912C1 (https=)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE4118912A DE4118912C1 (https=) 1991-06-08 1991-06-08
EP92108912A EP0530447B1 (de) 1991-06-08 1992-05-27 Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
DK92108912.4T DK0530447T3 (da) 1991-06-08 1992-05-27 Fremgangsmåde til rensning af IgG-monoklonale antistoffer
ES92108912T ES2108059T3 (es) 1991-06-08 1992-05-27 Procedimiento para la purificacion de anticuerpos monoclonales igg.
DE59208982T DE59208982D1 (de) 1991-06-08 1992-05-27 Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
AT92108912T ATE159532T1 (de) 1991-06-08 1992-05-27 Verfahren zur reinigung von igg-monoklonalen antikörpern
JP4145807A JP2644946B2 (ja) 1991-06-08 1992-06-05 ＩｇＧ− モノクロナール抗体の精製方法及びその使用方法
GR970403248T GR3025603T3 (en) 1991-06-08 1997-12-05 Process for purifying IgG monoclonal antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4118912A DE4118912C1 (https=) 1991-06-08 1991-06-08

Publications (1)

Publication Number Publication Date
DE4118912C1 true DE4118912C1 (https=) 1992-07-02

Family

ID=6433511

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4118912A Expired - Fee Related DE4118912C1 (https=) 1991-06-08 1991-06-08
DE59208982T Expired - Lifetime DE59208982D1 (de) 1991-06-08 1992-05-27 Verfahren zur Reinigung von IgG-monoklonalen Antikörpern

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59208982T Expired - Lifetime DE59208982D1 (de) 1991-06-08 1992-05-27 Verfahren zur Reinigung von IgG-monoklonalen Antikörpern

Country Status (7)

Country Link
EP (1) EP0530447B1 (https=)
JP (1) JP2644946B2 (https=)
AT (1) ATE159532T1 (https=)
DE (2) DE4118912C1 (https=)
DK (1) DK0530447T3 (https=)
ES (1) ES2108059T3 (https=)
GR (1) GR3025603T3 (https=)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029334A1 (fr) * 1993-06-14 1994-12-22 Association Pour L'essor De La Transfusion Sanguine Dans La Region Du Nord Concentre d'immunoglobulines g a usage therapeutique et procede de production dudit concentre
WO1999064462A1 (en) 1998-06-09 1999-12-16 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
WO2001072844A3 (en) * 2000-03-30 2002-04-11 Amersham Biosciences Ab A METHOD OF PRODUCING IgG
US8715652B2 (en) 2003-11-18 2014-05-06 Csl Behring Ag Immunoglobulin preparations having increased stability
US9241897B2 (en) 2010-02-04 2016-01-26 Csl Behring Ag Immunoglobulin preparation
US9422364B2 (en) 2010-02-26 2016-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US12144861B2 (en) 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
DK2270044T3 (en) 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
CN101679509A (zh) 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
WO2009058769A1 (en) * 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
JP2012513425A (ja) 2008-12-22 2012-06-14 エフ．ホフマン−ラ ロシュ アーゲー 免疫グロブリンの精製
CN102762585B (zh) 2010-02-12 2016-01-20 DPx控股有限公司 单一单元抗体纯化
CN103118708B (zh) 2010-09-14 2015-08-26 霍夫曼-拉罗奇有限公司 用于纯化聚乙二醇化的促红细胞生成素的方法
AU2011325341B2 (en) * 2010-11-01 2015-12-17 Dpx Holdings B.V. Single unit ion exchange chromatography antibody purification
JP6116565B2 (ja) 2011-08-25 2017-04-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 陽イオンおよび陰イオン交換クロマトグラフィー法
EP2596812B1 (de) * 2011-11-22 2015-06-10 Heraeus Medical GmbH Sterilisation von polymerisierbaren Monomeren
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
KR102470282B1 (ko) 2016-07-15 2022-11-24 에프. 호프만-라 로슈 아게 Ｐｅｇ화 에리트로포이에틴을 정제하기 위한 방법
JP2022523063A (ja) * 2019-01-30 2022-04-21 アムジエン・インコーポレーテツド アフリベルセプトの属性、並びにその特性決定及び修飾方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144028A2 (en) * 1983-11-25 1985-06-12 J.T. Baker Inc. Purification of type IgG monoclonal antibodies
EP0310719A1 (en) * 1987-10-05 1989-04-12 Becton, Dickinson and Company Method for purification of antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144028A2 (en) * 1983-11-25 1985-06-12 J.T. Baker Inc. Purification of type IgG monoclonal antibodies
EP0310719A1 (en) * 1987-10-05 1989-04-12 Becton, Dickinson and Company Method for purification of antibodies

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029334A1 (fr) * 1993-06-14 1994-12-22 Association Pour L'essor De La Transfusion Sanguine Dans La Region Du Nord Concentre d'immunoglobulines g a usage therapeutique et procede de production dudit concentre
FR2706466A1 (fr) * 1993-06-14 1994-12-23 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
WO1999064462A1 (en) 1998-06-09 1999-12-16 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
EP1493751A1 (en) * 1998-06-09 2005-01-05 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
CZ297199B6 (cs) * 1998-06-09 2006-09-13 Statens Serum Institut Zpusob výroby imunoglobulinu pro intravenózní podání a dalsích imunoglobulinových produktu
EP2270044A1 (en) * 1998-06-09 2011-01-05 CSL Behring AG Liquid immunoglobulin G (lgG) product
EP2272870A1 (en) * 1998-06-09 2011-01-12 CSL Behring AG Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
WO2001072844A3 (en) * 2000-03-30 2002-04-11 Amersham Biosciences Ab A METHOD OF PRODUCING IgG
US8715652B2 (en) 2003-11-18 2014-05-06 Csl Behring Ag Immunoglobulin preparations having increased stability
US8906368B2 (en) 2003-11-18 2014-12-09 Zlb Behring Ag Immunoglobulin preparations having increased stability
US9241897B2 (en) 2010-02-04 2016-01-26 Csl Behring Ag Immunoglobulin preparation
US10137197B2 (en) 2010-02-04 2018-11-27 Csl Behring Ag Process for preparing an immunoglobulin preparation
US12194101B2 (en) 2010-02-04 2025-01-14 Csl Behring Ag Process for preparing an immunoglobulin preparation
US9422364B2 (en) 2010-02-26 2016-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US10434176B2 (en) 2010-02-26 2019-10-08 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US11419936B2 (en) 2010-02-26 2022-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US12558422B2 (en) 2010-02-26 2026-02-24 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US12144861B2 (en) 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Also Published As

Publication number Publication date
GR3025603T3 (en) 1998-03-31
DK0530447T3 (da) 1998-01-12
DE59208982D1 (de) 1997-11-27
ES2108059T3 (es) 1997-12-16
JPH07267997A (ja) 1995-10-17
JP2644946B2 (ja) 1997-08-25
EP0530447A3 (en) 1993-08-18
ATE159532T1 (de) 1997-11-15
EP0530447B1 (de) 1997-10-22
EP0530447A2 (de) 1993-03-10

Similar Documents

Publication Publication Date Title
DE4118912C1 (https=)
DE69424545T2 (de) Verfahren zur herstellung von immunoglobulin g konzentrat
EP0447585B1 (de) Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates
DE69729217T3 (de) Methode zur chromatographischen entfernung von prionen
DE68913422T2 (de) Entfernen von Verfahrenschemikalien aus labilen biologischen Gemischen durch hydrophobe Austauschchromatographie.
DE3686927T2 (de) Neovaskularisierungsinhibitoren und deren herstellung.
DE3927111C3 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE69225976T2 (de) Colostrum fraktion und ihre verwendung als additiv beim zellkulturmedium
CH644520A5 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors.
DE69635661T2 (de) Methode zur reinigung von thrombopoietin
EP1074615A1 (de) Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
AT399095B (de) Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
DE69229068T2 (de) Verfahren zur Reinigung von menschlichem Albumin
EP0013901A1 (de) Verfahren zur Herstellung einer für die intravenöse Applikation geeigneten Immunglobulinlösung, die IgM in ankonzentrierter Form enthält
DE3733181C1 (de) Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates
DE69027995T2 (de) Reinigungsverfahren von transformierendem wachstumsfaktor (tgf)
EP0764658A1 (de) Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen
EP1194442B1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
EP1326893A2 (de) Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung
EP0247998A2 (de) Verfahren zur Inaktivierung von vermehrungsfähigen filtrierbaren Krankheitserregern
DE69609054T2 (de) Ein prozess für die herstellung von faktor ix biologischen ursprungs
EP0835880A1 (de) Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
DE68907933T2 (de) Therapeutisches Mittel für Thrombocytopenia.
DE3645095C2 (de) Antikörper
DE3750664T2 (de) Throminbindende Substanz und Verfahren zu ihrer Herstellung.

Legal Events

Date Code Title Description
8100 Publication of patent without earlier publication of application
D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee